Albert P S
Biometric Research Branch, National Cancer Institute, CTEP, DCTDC Executive Plaza North, 6130 Executive Blvd, MSC 7434 Bethesda, MD 20892-7434, USA.
Stat Med. 1999 Jul 15;18(13):1707-32. doi: 10.1002/(sici)1097-0258(19990715)18:13<1707::aid-sim138>3.0.co;2-h.
Longitudinal data is often collected in clinical trials to examine the effect of treatment on the disease process over time. This paper reviews and summarizes much of the methodological research on longitudinal data analysis from the perspective of clinical trials. We discuss methodology for analysing Gaussian and discrete longitudinal data and show how these methods can be applied to clinical trials data. We illustrate these methods with five examples of clinical trials with longitudinal outcomes. We also discuss issues of particular concern in clinical trials including sequential monitoring and adjustments for missing data. A review of current software for analysing longitudinal data is also provided. Published in 1999 by John Wiley & Sons, Ltd. This article is a US Government work and is the public domain in the United States.
在临床试验中经常收集纵向数据,以研究治疗对疾病进程随时间的影响。本文从临床试验的角度回顾并总结了纵向数据分析的许多方法学研究。我们讨论了分析高斯和离散纵向数据的方法,并展示了这些方法如何应用于临床试验数据。我们用五个具有纵向结果的临床试验例子来说明这些方法。我们还讨论了临床试验中特别关注的问题,包括序贯监测和缺失数据的调整。此外,还对当前用于分析纵向数据的软件进行了综述。由约翰·威利父子有限公司于1999年出版。本文是美国政府作品,在美国属于公共领域。